Trillium Therapeutics
€5.23
3
-€0.40-7.11% Wednesday 09:08
Statistics
Day High
-
Day Low
-
52W High
-
52W Low
-
Volume
-
Avg. Volume
-
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-
Earnings
11AugExpected
Q2 2021
Q3 2021
Q4 2021
Q1 2022
Q2 2022
999
333
-333
-999
Expected EPS
N/A
Actual EPS
N/A
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
About
Trillium Therapeutics Inc., a clinical stage immuno-oncology company, develops therapies for the treatment of cancer. Its include TTI-622, a SIRPa-IgG4 Fc fusion protein that is designed to enhance macrophage-mediated phagocytosis and anti-tumor activity by blocking the CD47, which is in Phase 1 clinical trials; and TTI-621, a SIRPa-IgG1 Fc fusion protein, which is in Phase 1 clinical trials and generates a signal blocking the CD47 for advanced relapsed or refractory hematologic malignancies, and solid tumors and mycosis fungoides. The company was formerly known as Stem Cell Therapeutics Corp. and changed its name to Trillium Therapeutics Inc. in June 2014. Trillium Therapeutics Inc. was incorporated in 2004 is based in Mississauga, Canada.
Show more...
CEO
Dr. Jan Skvarka
Employees
33
Country
Germany
Listings
0 Comments
Share your thoughts
FAQ
What is Trillium Therapeutics stock price today?▼
The current price of R5WP.F is €5.23 EUR — it has decreased by -7.11% in the past 24 hours. Watch Trillium Therapeutics stock price performance more closely on the chart.
What is Trillium Therapeutics stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Frankfurt Exchange exchange Trillium Therapeutics stocks are traded under the ticker R5WP.F.
How many employees does Trillium Therapeutics have?▼
As of September 04, 2026, the company has 33 employees.
In which sector is Trillium Therapeutics located?▼
Trillium Therapeutics operates in the Health & Wellness sector.
When did Trillium Therapeutics complete a stock split?▼
Trillium Therapeutics has not had any recent stock splits.
Where is Trillium Therapeutics headquartered?▼
Trillium Therapeutics is headquartered in Mississauga, Germany.